// App-Quantinova.ai

3372 : US Experience with Recombinant Factor VIIa (rFVIIa) for Surgery in Acquired Hemophilia (AH): Analysis From the Hemophilia and Thrombosis Research Society (HTRS) Registry

Researchers

Presenter

  • Alice D. Ma

Principal Investigators

  • Craig M. Kessler

  • Margaret Fisher

  • Robert Z. Gut

  • David L. Cooper

Medical Centers

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

Locations

  • United States

Companies

  • Novo Nordisk A/S

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Hemophilia

  • Venous thrombosis

  • Hematoma

Biomarkers

  • N/A

Drug/Treatment

  • rFVIIa

  • Prothrombin complex

  • rFVIII

  • Desmopressin

  • FVIII

  • Hemostatic Solution

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved